Male Infertility study: Platelet rich plasma
Official title Platelet Rich Plasma Testis Treatment for Infertile Men
ClinicalTrials.gov ID: NCT05479474
What this study is testing
What is Platelet Rich Plasma?
An investigational biological treatment being studied for male infertility.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to see whether this injection improves the chance of retrieving sperm and helps IVF results in men who have already had a negative TESE.
- Who it's for
- Men who are infertile, have non‑obstructive azoospermia, and have had a failed TESE.
- What's involved
- Participants will receive an injection of their own platelet‑rich plasma into the testicle, then undergo follow‑up sperm retrieval and IVF procedures. No other treatments are added.
- Time commitment
- The study lasts until the sperm retrieval and IVF are completed, with a few clinic visits for the injection and follow‑up tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Men over the age of 18 diagnosed with NOA and at least one failed TESE, negative mapping or negative biopsy
The study team makes the final eligibility decision.
Where it is enrolling
- Stanford, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Stanford, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.